SIR, Some time ago we gave an account in this journal of our unsuccessful search for serological cross-reactions between Yersinia enterocolitica and lymphocytes from both HLA B27 normal subjects (B27+ AS-) and HLA B27+ ankylosing spondylitis (AS) patients (B27+ AS+). Our purpose in conducting these experiments had been to see if we could find support for the molecular mimicry hypotheses of AS.'
We have continued this search and now wish to report some unexpected results which are in themselves of potential interest and at the same time demonstrate the need for caution in the interpretations of results in experiments concerning bacterial antisera and human lymphocytes.
Our methods for antiserum production and lymphocytotoxicity (LCT) testing were basically the same as those used previously' but with some modifications. We changed to using formalised vaccines for the preparation of rabbit antisera following the report by Geczy et al.2 that the putative cross-reacting klebsiella antigen is heat-labile, and for the LCT we used antisera in dilutions as follows: neat, 1 + 1, 1+2, 1+3, 1+4, and 1+5, and each of these dilutions with complement dilutions as follows: neat, 1 + 1, 1+2, 1+4. In addition to the Y. enterocolitica sera we also made one from Klebsiella pneumoniae (obtained from Dr A. Ebringer, Middlesex Hospital patient 100).
When we used the formalised vaccine prepared antisera we obtained positive results with Y. enterocolitica type 9 antiserum even in the standard LCT test described in our previous report, and after these initial positive results we included preimmunisation sera in our tests. As a result of these tests we concluded that the positive results were due to differences in the rabbits we were using, not the change in the method of vaccine production. The results are shown in Table 1 and indicate clearly the preimmunisation serum, that is, apparently normal rabbit serum is capable of causing the cytotoxic effects, and in some cases the kill rate was higher with the preimmunisation serum than that with the postimmunisation one. The fact that the serum contained a high titre of Y. enterocolitica type 9 as measured by haemagglutination and gel-diffusion techniques appears to be totally irrelevant. We obtained a few positive results with the K. pneumoniae serum, but discontinued the use of it because the kill rate was not as high as it was with the Y. enterocolitica. However, those few results indicate that the LCT factor was present in the serum of 2 out of 12 rabbits used in the experiments.
Our results do not invalidate the work of Geczy et al. 2 concerning the modification of B27+ AS-lymphocytes by klebsiella culture filtrates, so that they become susceptible to lysis by anti-klebsiella sera.
However, it is possible that some of the observations of influenced by the so-called 'golden section', estimating short below 6-19 cm along the scale and long above that distance. As the methodology of the study which suggested this was not typical of clinical use of the VAS, we asked 100 patients attending the physiotherapy department in South Tees to estimate their pain on a vertical VAS on arrival at the treatment unit. They were then prepared for treatment, and before therapy was commenced filled in a second VAS without having sight of their first scale. When the results of the first and second measurements were compared, 52 % of the second estimates fell short, 17% were equal, and 31 % were longer than the first. The results are summarised in Table 1 . When results from patients whose original score was 6 cm or less were compared with those between 6-1 cm and 10 cm, no significant difference was found between the 2 groups (Table 2) .
Scott and Huskisson2 suggested that patients who are not allowed to see their original score tend to over-estimate at a second attempt. Our findings do not accord with theirs, as 52 % of our patients gave a smaller estimate on their second attempt, only 31 % increasing.
Although we agree with Dixon and Bird1 that reproducibility is best near the ends of the scale, we did not find the change in estimate from long to short at 6 cm which they described. We believe this is due to the fact that their subjects were normal volunteers who were trying to memorise the position of an arbitrary line, whereas we used patients who have their own built-in pain to use as a reference point. It appears, therefore, that the golden section phenomenon which they described is an artefact induced by using normal volunteers rather than a real problem in clinical use of visual analogue scales.
SIR, We read the above letter of Dr Dawes and Dr Haslock with interest. Our earlier study' simply sought to draw attention to possible variation in reproducibility along the length of a VAS that might occur if we followed recommendations2 to allow subjects access to their previous scores. All workers now seem agreed that this variation occurs,3 and our subsequent studies on serial exposure to visual analogue scales also confirm it. 4 We selected normal volunteers in order to exclude any further variation that might arise as patients attempted to reproduce the modality measured (be it pain, stiffness, or sleep) on a 10 cm line. To have investigated this would have involved inflicting pain or stiffness on our volunteers. Alternatively we could have used patients but felt that their subjective interpretation of pain (or stiffness) would have added too great a source of error.
We suggested in our paper that errors resulting from the golden section' phenomenon are certainly in evidence but are a less likely source of error than a variety of other factors that appertain in the clinic. We are therefore pleased that and some normal rabbit sera. HLA B27, ankylosing spondylitis, 
